Details for Patent: 9,731,082
✉ Email this page to a colleague
Which drugs does patent 9,731,082 protect, and when does it expire?
Patent 9,731,082 protects DILAUDID and DILAUDID-HP and is included in one NDA.
This patent has eight patent family members in seven countries.
Summary for Patent: 9,731,082
| Title: | Drug container |
| Abstract: | The present invention relates to an assembly (101) comprising: an injection device (1) comprising a container (2) for a product, said container comprising a distal tip (3), an adaptor (5) comprising a ring (6) mounted onto said distal tip (3), characterized in that said assembly (101) further comprises a heat-shrinkable film (9) covering part (2a) of said container (2) and part (5a) of said adaptor (5), said film (9) maintaining said adaptor (5) blocked in rotation and in translation with respect to said container (2) when said film (9) is in its heat-shrunk condition. The invention further relates to a method for manufacturing such an assembly. |
| Inventor(s): | Vernizeau; Michel (Valence, FR), Foucher; Cedric (Grenoble, FR), Lefebvre; Lionel (Varois et Chaignot, FR) |
| Assignee: | Fresenius Kabi Deutschland GmbH (Bad Homburg, DE) |
| Application Number: | 13/132,285 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,731,082 |
|
Patent Claim Types: see list of patent claims | Use; Device; Dosage form; |
Drugs Protected by US Patent 9,731,082
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Usa | DILAUDID | hydromorphone hydrochloride | INJECTABLE;INJECTION | 019034-006 | Jan 16, 2020 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Fresenius Kabi Usa | DILAUDID | hydromorphone hydrochloride | INJECTABLE;INJECTION | 019034-007 | Feb 10, 2017 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Fresenius Kabi Usa | DILAUDID | hydromorphone hydrochloride | INJECTABLE;INJECTION | 019034-003 | Apr 30, 2009 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Fresenius Kabi Usa | DILAUDID | hydromorphone hydrochloride | INJECTABLE;INJECTION | 019034-004 | Apr 30, 2009 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,731,082
| PCT Information | |||
| PCT Filed | December 02, 2008 | PCT Application Number: | PCT/IB2008/003736 |
| PCT Publication Date: | June 10, 2010 | PCT Publication Number: | WO2010/064074 |
International Family Members for US Patent 9,731,082
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Denmark | 2376147 | ⤷ Try a Trial | |||
| European Patent Office | 2376147 | ⤷ Try a Trial | |||
| Spain | 2693123 | ⤷ Try a Trial | |||
| Hungary | E041597 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
